Home › 2 Bay Area biotechs set to test IPO market: Virobay, Atara Biotherapeutics
 

Keywords :   


2 Bay Area biotechs set to test IPO market: Virobay, Atara Biotherapeutics

2014-10-13 21:42:00| Biotech - Topix.net

Atara Biotherapeutics, led by Dr. Isaac Ciechanover, filed plans to raise up to $92 million this week in an IPO that was put off in July. The Bay Area's fourth-quarter IPO season swings back into action with a pair of biotech offerings this week from Atara Biotherapeutics and Virobay.

Tags: set area test market

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.10Atlantic Tropical Weather Outlook
05.10Eastern North Pacific Tropical Weather Outlook
05.10Hurricane Leslie Graphics
05.10Hurricane Leslie Forecast Discussion Number 11
05.10Hurricane Leslie Wind Speed Probabilities Number 11
05.10Hurricane Leslie Public Advisory Number 11
05.10Summary for Hurricane Leslie (AT3/AL132024)
05.10Hurricane Leslie Forecast Advisory Number 11
More »